DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Royal Sense Ltd?

Royal Sense Ltd has a price-to-earnings (PE) ratio of 8.0 in the Healthcare sector.

What is the market capitalisation of Royal Sense Ltd?

Royal Sense Ltd has a market capitalisation of approximately ₹57 crore.

Royal Sense Ltd

ROYALSENSELTD·NSE·Healthcare

₹0.00▲ +0.00 (+0.00%)

⚠️Trading suspended. Not a live price.

Healthcare · Medical Equipment

High-quality returns — 21% on equity

52W₹85

₹310-38%

Open

—

High

—

Low

—

Prev Close

—

Volume

—

VWAP

—

Snapshot

Key fundamentals

Market Cap

₹57 Cr

P/E Ratio

8.00Cheap

P/B Ratio

1.51

EPS

₹13.36

Book Value

₹75.70

ROE

21.00%Strong

ROCE

26.00%Efficient

Dividend Yield

0.00%

Debt / Equity

0.33Moderate

Face Value

₹10.00

52W High

₹309.75

52W Low

₹85.00

Sector

Healthcare

Industry

Medical Equipment

Fairly Valued

Narrow moatMedium uncertainty

Fair value estimate

₹118

No recent traded price

BearFair valueBull

₹100₹118₹151

/100

Business quality — Solid

Growth 50Profitability 53Efficiency 90Valuation 92

Plain English

Our view

High-quality returns — 21% on equity
Low debt relative to equity

Strengths

Low debt relative to equity
Strong returns on equity (21%)
Capital is working hard (ROCE 26%)
Reasonably priced at 8× earnings

How we got there

Fair value methods

Residual income

21% ROE fading to 13% over ~10 yrs, on ₹76 book

₹109

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹151

Analyst target

No analyst coverage

—

Blended fair value₹118

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Strong returns on equity (21%)
Capital is working hard (ROCE 26%)
Reasonably priced at 8× earnings
Promoters hold a controlling stake

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

8.0Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

21.0%Strong

Above 15% is considered healthy for Indian equities

ROCE

26.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.33Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹57 Cr

P/B

1.51

EPS

₹13.36

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

Attractive

P/E 8.0×

Growth

N/A

No history

Profitability

Excellent

21.0% ROE

Financial health

Comfortable

D/E 0.33

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

No growth history

Not enough annual history to compute CAGR.

Profile

Cons

Though the company is reporting repeated profits, it is not paying out dividend

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

62%

Promoter

Promoters

62.2%0.00

Public

25.7%+0.86

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

12.1%

Total shareholders

416+6 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter62.24%

Public25.69%

Others12.07%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2023, Royal Sense Ltd specializes in medical device and pharmaceutical trading.[1]

Royal Sense Ltd valuation & research

Deep-dive tools with DocStoX's fair-value estimate, ratios and peers.

Fair Value Intrinsic Value DCF Valuation Financial Ratios Peers

Royal Sense Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

SUN PHARMACEUTICAL IND L DIVI S LABORATORIES LTD TORRENT PHARMACEUTICALS L APOLLO HOSPITALS ENTER. L ZYDUS LIFESCIENCES LTD CIPLA LTD LUPIN LIMITED MAX HEALTHCARE INS LTD MANKIND PHARMA LIMITED DR. REDDY S LABORATORIES AUROBINDO PHARMA LTD LAURUS LABS LIMITED

Compare Royal Sense Ltd with peers

Royal Sense Ltd vs SUN PHARMACEUTICAL IND L Royal Sense Ltd vs DIVI S LABORATORIES LTD Royal Sense Ltd vs TORRENT PHARMACEUTICALS L Royal Sense Ltd vs APOLLO HOSPITALS ENTER. L Royal Sense Ltd vs ZYDUS LIFESCIENCES LTD Royal Sense Ltd vs CIPLA LTD

Royal Sense Ltd

Key fundamentals

Key statistics

Recent changes

News impact

Overview

Trading activity

Technical signals

Growth (CAGR)

Company information

Cons

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership breakdown

Ownership over time

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Frequently asked questions

Royal Sense Ltd valuation & research

Royal Sense Ltd peers in Healthcare

Compare Royal Sense Ltd with peers

Key statistics

Recent changes

News impact

Trading activity

Technical signals

Growth (CAGR)

Company information

Cons

Ownership breakdown

Ownership over time

Frequently asked questions